XML 105 R92.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Based Awards and Other Equity Instruments - Summary of RSU Activity (Parenthetical) (Details) - $ / shares
12 Months Ended
Jul. 01, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Weighted-average grant date fair value   $ 9.93 $ 18.40 $ 10.08
Restricted Stock Units        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
RSUs withheld to satisfy withholding tax requirements   820,000    
Restricted stock units, Granted [1]   7,059,000    
Matt Goldberg | Restricted Stock Units        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Restricted stock units, Granted 258,000   106,382  
Weighted-average grant date fair value $ 18.47      
Stock awards vesting term This service-based RSU award shall vest over four years, with 25% vesting on July 1, 2023 and 6.25% of the remaining award vesting in equal quarterly installments commencing thereafter, subject to the CEO’s continuous employment with the Company.      
Percentage of stock based awards allowed to vest as first installment     25.00%  
Requisite service period for estimated grant-date fair value of stock awards Jul. 01, 2026      
Matt Goldberg | Restricted Stock Units | Tranche One        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Percentage of stock based awards allowed to vest as first installment 25.00%      
Matt Goldberg | Restricted Stock Units | Tranche Two        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Percentage of stock based awards allowed to vest as first installment 6.25%      
[1] Inclusive of approximately 258,000 RSUs awarded to our CEO during July 2022. The estimated grant-date fair value per RSU, based on the quoted price of our common stock on the date of grant, was $18.47. This service-based RSU award shall vest over four years, with 25% vesting on July 1, 2023 and 6.25% of the remaining award vesting in equal quarterly installments commencing thereafter, subject to the CEO’s continuous employment with the Company. The estimated grant-date fair value of this award will be amortized on a straight-line basis over the requisite service period through July 1, 2026.